Market Reports Center

Global Interventional Oncology Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023


Report Details

Global Interventional Oncology Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

SKU GIRJAN101905
Category Life Sciences
Publisher GlobalInfoResearch
Pages 139
Published Jan-19
Request Discount Pay by Wire/Invoice

Description

Interventional oncology is a subspecialty field of interventional radiology that deals with the diagnosis and treatment of cancerand cancer-related problems using targeted minimally invasive procedures performed under image guidance.

Scope of the Report:
This report studies the Interventional Oncology market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Interventional Oncology market by product type and applications/end industries.
Interventional oncology has developed to a separate pillar of modern oncology and it employs X-ray, ultrasound, computed tomography (CT) or magnetic resonance imaging (MRI) to help guide miniaturized instruments (e.g. biopsy needles, ablation electrodes, intravascular catheters) to allow targeted and precise treatment of solid tumours located in various organs of the human body, including but not limited to the liver, kidneys, lungs, and bones. Interventional oncology treatments are routinely carried out by interventional radiologists in appropriate settings and facilities.
The global Interventional Oncology market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Interventional Oncology.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers
Boston Scientific
BTG
Medtronic
Merit Medical
Terumo
Accuray
Alpinion Medical Systems
Angiodynamics
Atricure
Baylis Medical
Bovie Medical
Brainlab
Bsd Medical
C. R. Bard
C2 Therapeutics
Cardiofocus
Cook Medical
Eckert And Ziegler Bebig
Edap Tms
Elekta
Galil Medical
Healthtronics
Insightec
Medwaves
Mermaid Medical
Microsulis Medical
Monteris Medical

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Radiation Therapy
Ablation
Particle Embolization

Market Segment by Applications, can be divided into
Liver Cancer
Lung Cancer
Kidney Cancer
Bone Cancer
Breast Cancer
Prostate Cancer
Pancreatic Cancer


News/Press Release

Table of Content

Table of Contents

1 Interventional Oncology Market Overview
1.1 Product Overview and Scope of Interventional Oncology
1.2 Classification of Interventional Oncology by Types
1.2.1 Global Interventional Oncology Revenue Comparison by Types (2017-2023)
1.2.2 Global Interventional Oncology Revenue Market Share by Types in 2017
1.2.3 Radiation Therapy
1.2.4 Ablation
1.2.5 Particle Embolization
1.3 Global Interventional Oncology Market by Application
1.3.1 Global Interventional Oncology Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Liver Cancer
1.3.3 Lung Cancer
1.3.4 Kidney Cancer
1.3.5 Bone Cancer
1.3.6 Breast Cancer
1.3.7 Prostate Cancer
1.3.8 Pancreatic Cancer
1.4 Global Interventional Oncology Market by Regions
1.4.1 Global Interventional Oncology Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Interventional Oncology Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Interventional Oncology Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Interventional Oncology Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Interventional Oncology Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Interventional Oncology Status and Prospect (2013-2023)
1.5 Global Market Size of Interventional Oncology (2013-2023)
2 Manufacturers Profiles
2.1 Boston Scientific
2.1.1 Business Overview
2.1.2 Interventional Oncology Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Boston Scientific Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.2 BTG
2.2.1 Business Overview
2.2.2 Interventional Oncology Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 BTG Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.3 Medtronic
2.3.1 Business Overview
2.3.2 Interventional Oncology Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Medtronic Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.4 Merit Medical
2.4.1 Business Overview
2.4.2 Interventional Oncology Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Merit Medical Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.5 Terumo
2.5.1 Business Overview
2.5.2 Interventional Oncology Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Terumo Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.6 Accuray
2.6.1 Business Overview
2.6.2 Interventional Oncology Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Accuray Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.7 Alpinion Medical Systems
2.7.1 Business Overview
2.7.2 Interventional Oncology Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Alpinion Medical Systems Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.8 Angiodynamics
2.8.1 Business Overview
2.8.2 Interventional Oncology Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Angiodynamics Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.9 Atricure
2.9.1 Business Overview
2.9.2 Interventional Oncology Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Atricure Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.10 Baylis Medical
2.10.1 Business Overview
2.10.2 Interventional Oncology Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Baylis Medical Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.11 Bovie Medical
2.11.1 Business Overview
2.11.2 Interventional Oncology Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Bovie Medical Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.12 Brainlab
2.12.1 Business Overview
2.12.2 Interventional Oncology Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Brainlab Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.13 Bsd Medical
2.13.1 Business Overview
2.13.2 Interventional Oncology Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Bsd Medical Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.14 C. R. Bard
2.14.1 Business Overview
2.14.2 Interventional Oncology Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 C. R. Bard Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.15 C2 Therapeutics
2.15.1 Business Overview
2.15.2 Interventional Oncology Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 C2 Therapeutics Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.16 Cardiofocus
2.16.1 Business Overview
2.16.2 Interventional Oncology Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Cardiofocus Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.17 Cook Medical
2.17.1 Business Overview
2.17.2 Interventional Oncology Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Cook Medical Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.18 Eckert And Ziegler Bebig
2.18.1 Business Overview
2.18.2 Interventional Oncology Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Eckert And Ziegler Bebig Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.19 Edap Tms
2.19.1 Business Overview
2.19.2 Interventional Oncology Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Edap Tms Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.20 Elekta
2.20.1 Business Overview
2.20.2 Interventional Oncology Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Elekta Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.21 Galil Medical
2.21.1 Business Overview
2.2.2 Interventional Oncology Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Galil Medical Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.22 Healthtronics
2.22.1 Business Overview
2.22.2 Interventional Oncology Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 Healthtronics Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.23 Insightec
2.23.1 Business Overview
2.23.2 Interventional Oncology Type and Applications
2.23.2.1 Product A
2.23.2.2 Product B
2.23.3 Insightec Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.24 Medwaves
2.24.1 Business Overview
2.24.2 Interventional Oncology Type and Applications
2.24.2.1 Product A
2.24.2.2 Product B
2.24.3 Medwaves Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.25 Mermaid Medical
2.25.1 Business Overview
2.25.2 Interventional Oncology Type and Applications
2.25.2.1 Product A
2.25.2.2 Product B
2.25.3 Mermaid Medical Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.26 Microsulis Medical
2.26.1 Business Overview
2.26.2 Interventional Oncology Type and Applications
2.26.2.1 Product A
2.26.2.2 Product B
2.26.3 Microsulis Medical Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.27 Monteris Medical
2.27.1 Business Overview
2.27.2 Interventional Oncology Type and Applications
2.27.2.1 Product A
2.27.2.2 Product B
2.27.3 Monteris Medical Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
3 Global Interventional Oncology Market Competition, by Players
3.1 Global Interventional Oncology Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Interventional Oncology Players Market Share
3.2.2 Top 10 Interventional Oncology Players Market Share
3.3 Market Competition Trend
4 Global Interventional Oncology Market Size by Regions
4.1 Global Interventional Oncology Revenue and Market Share by Regions
4.2 North America Interventional Oncology Revenue and Growth Rate (2013-2018)
4.3 Europe Interventional Oncology Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Interventional Oncology Revenue and Growth Rate (2013-2018)
4.5 South America Interventional Oncology Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Interventional Oncology Revenue and Growth Rate (2013-2018)
5 North America Interventional Oncology Revenue by Countries
5.1 North America Interventional Oncology Revenue by Countries (2013-2018)
5.2 USA Interventional Oncology Revenue and Growth Rate (2013-2018)
5.3 Canada Interventional Oncology Revenue and Growth Rate (2013-2018)
5.4 Mexico Interventional Oncology Revenue and Growth Rate (2013-2018)
6 Europe Interventional Oncology Revenue by Countries
6.1 Europe Interventional Oncology Revenue by Countries (2013-2018)
6.2 Germany Interventional Oncology Revenue and Growth Rate (2013-2018)
6.3 UK Interventional Oncology Revenue and Growth Rate (2013-2018)
6.4 France Interventional Oncology Revenue and Growth Rate (2013-2018)
6.5 Russia Interventional Oncology Revenue and Growth Rate (2013-2018)
6.6 Italy Interventional Oncology Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Interventional Oncology Revenue by Countries
7.1 Asia-Pacific Interventional Oncology Revenue by Countries (2013-2018)
7.2 China Interventional Oncology Revenue and Growth Rate (2013-2018)
7.3 Japan Interventional Oncology Revenue and Growth Rate (2013-2018)
7.4 Korea Interventional Oncology Revenue and Growth Rate (2013-2018)
7.5 India Interventional Oncology Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Interventional Oncology Revenue and Growth Rate (2013-2018)
8 South America Interventional Oncology Revenue by Countries
8.1 South America Interventional Oncology Revenue by Countries (2013-2018)
8.2 Brazil Interventional Oncology Revenue and Growth Rate (2013-2018)
8.3 Argentina Interventional Oncology Revenue and Growth Rate (2013-2018)
8.4 Colombia Interventional Oncology Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Interventional Oncology by Countries
9.1 Middle East and Africa Interventional Oncology Revenue by Countries (2013-2018)
9.2 Saudi Arabia Interventional Oncology Revenue and Growth Rate (2013-2018)
9.3 UAE Interventional Oncology Revenue and Growth Rate (2013-2018)
9.4 Egypt Interventional Oncology Revenue and Growth Rate (2013-2018)
9.5 Nigeria Interventional Oncology Revenue and Growth Rate (2013-2018)
9.6 South Africa Interventional Oncology Revenue and Growth Rate (2013-2018)
10 Global Interventional Oncology Market Segment by Type
10.1 Global Interventional Oncology Revenue and Market Share by Type (2013-2018)
10.2 Global Interventional Oncology Market Forecast by Type (2018-2023)
10.3 Radiation Therapy Revenue Growth Rate (2013-2023)
10.4 Ablation Revenue Growth Rate (2013-2023)
10.5 Particle Embolization Revenue Growth Rate (2013-2023)
11 Global Interventional Oncology Market Segment by Application
11.1 Global Interventional Oncology Revenue Market Share by Application (2013-2018)
11.2 Interventional Oncology Market Forecast by Application (2018-2023)
11.3 Liver Cancer Revenue Growth (2013-2018)
11.4 Lung Cancer Revenue Growth (2013-2018)
11.5 Kidney Cancer Revenue Growth (2013-2018)
11.6 Bone Cancer Revenue Growth (2013-2018)
11.7 Breast Cancer Revenue Growth (2013-2018)
11.8 Prostate Cancer Revenue Growth (2013-2018)
11.9 Pancreatic Cancer Revenue Growth (2013-2018)
12 Global Interventional Oncology Market Size Forecast (2018-2023)
12.1 Global Interventional Oncology Market Size Forecast (2018-2023)
12.2 Global Interventional Oncology Market Forecast by Regions (2018-2023)
12.3 North America Interventional Oncology Revenue Market Forecast (2018-2023)
12.4 Europe Interventional Oncology Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Interventional Oncology Revenue Market Forecast (2018-2023)
12.6 South America Interventional Oncology Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Interventional Oncology Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Figures

List of Tables and Figures

Figure Interventional Oncology Picture
Table Product Specifications of Interventional Oncology
Table Global Interventional Oncology and Revenue (Million USD) Market Split by Product Type
Figure Global Interventional Oncology Revenue Market Share by Types in 2017
Figure Radiation Therapy Picture
Figure Ablation Picture
Figure Particle Embolization Picture
Table Global Interventional Oncology Revenue (Million USD) by Application (2013-2023)
Figure Interventional Oncology Revenue Market Share by Applications in 2017
Figure Liver Cancer Picture
Figure Lung Cancer Picture
Figure Kidney Cancer Picture
Figure Bone Cancer Picture
Figure Breast Cancer Picture
Figure Prostate Cancer Picture
Figure Pancreatic Cancer Picture
Table Global Market Interventional Oncology Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Interventional Oncology Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Interventional Oncology Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Interventional Oncology Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Interventional Oncology Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Interventional Oncology Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Interventional Oncology Revenue (Million USD) and Growth Rate (2013-2023)
Table Boston Scientific Basic Information, Manufacturing Base and Competitors
Table Boston Scientific Interventional Oncology Type and Applications
Table Boston Scientific Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
Table BTG Basic Information, Manufacturing Base and Competitors
Table BTG Interventional Oncology Type and Applications
Table BTG Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
Table Medtronic Basic Information, Manufacturing Base and Competitors
Table Medtronic Interventional Oncology Type and Applications
Table Medtronic Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
Table Merit Medical Basic Information, Manufacturing Base and Competitors
Table Merit Medical Interventional Oncology Type and Applications
Table Merit Medical Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
Table Terumo Basic Information, Manufacturing Base and Competitors
Table Terumo Interventional Oncology Type and Applications
Table Terumo Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
Table Accuray Basic Information, Manufacturing Base and Competitors
Table Accuray Interventional Oncology Type and Applications
Table Accuray Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
Table Alpinion Medical Systems Basic Information, Manufacturing Base and Competitors
Table Alpinion Medical Systems Interventional Oncology Type and Applications
Table Alpinion Medical Systems Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
Table Angiodynamics Basic Information, Manufacturing Base and Competitors
Table Angiodynamics Interventional Oncology Type and Applications
Table Angiodynamics Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
Table Atricure Basic Information, Manufacturing Base and Competitors
Table Atricure Interventional Oncology Type and Applications
Table Atricure Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
Table Baylis Medical Basic Information, Manufacturing Base and Competitors
Table Baylis Medical Interventional Oncology Type and Applications
Table Baylis Medical Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
Table Bovie Medical Basic Information, Manufacturing Base and Competitors
Table Bovie Medical Interventional Oncology Type and Applications
Table Bovie Medical Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
Table Brainlab Basic Information, Manufacturing Base and Competitors
Table Brainlab Interventional Oncology Type and Applications
Table Brainlab Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
Table Bsd Medical Basic Information, Manufacturing Base and Competitors
Table Bsd Medical Interventional Oncology Type and Applications
Table Bsd Medical Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
Table C. R. Bard Basic Information, Manufacturing Base and Competitors
Table C. R. Bard Interventional Oncology Type and Applications
Table C. R. Bard Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
Table C2 Therapeutics Basic Information, Manufacturing Base and Competitors
Table C2 Therapeutics Interventional Oncology Type and Applications
Table C2 Therapeutics Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
Table Cardiofocus Basic Information, Manufacturing Base and Competitors
Table Cardiofocus Interventional Oncology Type and Applications
Table Cardiofocus Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
Table Cook Medical Basic Information, Manufacturing Base and Competitors
Table Cook Medical Interventional Oncology Type and Applications
Table Cook Medical Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
Table Eckert And Ziegler Bebig Basic Information, Manufacturing Base and Competitors
Table Eckert And Ziegler Bebig Interventional Oncology Type and Applications
Table Eckert And Ziegler Bebig Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
Table Edap Tms Basic Information, Manufacturing Base and Competitors
Table Edap Tms Interventional Oncology Type and Applications
Table Edap Tms Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
Table Elekta Basic Information, Manufacturing Base and Competitors
Table Elekta Interventional Oncology Type and Applications
Table Elekta Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
Table Galil Medical Basic Information, Manufacturing Base and Competitors
Table Galil Medical Interventional Oncology Type and Applications
Table Galil Medical Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
Table Healthtronics Basic Information, Manufacturing Base and Competitors
Table Healthtronics Interventional Oncology Type and Applications
Table Healthtronics Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
Table Insightec Basic Information, Manufacturing Base and Competitors
Table Insightec Interventional Oncology Type and Applications
Table Insightec Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
Table Medwaves Basic Information, Manufacturing Base and Competitors
Table Medwaves Interventional Oncology Type and Applications
Table Medwaves Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
Table Mermaid Medical Basic Information, Manufacturing Base and Competitors
Table Mermaid Medical Interventional Oncology Type and Applications
Table Mermaid Medical Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
Table Microsulis Medical Basic Information, Manufacturing Base and Competitors
Table Microsulis Medical Interventional Oncology Type and Applications
Table Microsulis Medical Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
Table Monteris Medical Basic Information, Manufacturing Base and Competitors
Table Monteris Medical Interventional Oncology Type and Applications
Table Monteris Medical Interventional Oncology Revenue, Gross Margin and Market Share (2016-2017)
Table Global Interventional Oncology Revenue (Million USD) by Players (2013-2018)
Table Global Interventional Oncology Revenue Share by Players (2013-2018)
Figure Global Interventional Oncology Revenue Share by Players in 2016
Figure Global Interventional Oncology Revenue Share by Players in 2017
Figure Global Top 5 Players Interventional Oncology Revenue Market Share in 2017
Figure Global Top 10 Players Interventional Oncology Revenue Market Share in 2017
Figure Global Interventional Oncology Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Interventional Oncology Revenue (Million USD) by Regions (2013-2018)
Table Global Interventional Oncology Revenue Market Share by Regions (2013-2018)
Figure Global Interventional Oncology Revenue Market Share by Regions (2013-2018)
Figure Global Interventional Oncology Revenue Market Share by Regions in 2017
Figure North America Interventional Oncology Revenue and Growth Rate (2013-2018)
Figure Europe Interventional Oncology Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Interventional Oncology Revenue and Growth Rate (2013-2018)
Figure South America Interventional Oncology Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Interventional Oncology Revenue and Growth Rate (2013-2018)
Table North America Interventional Oncology Revenue by Countries (2013-2018)
Table North America Interventional Oncology Revenue Market Share by Countries (2013-2018)
Figure North America Interventional Oncology Revenue Market Share by Countries (2013-2018)
Figure North America Interventional Oncology Revenue Market Share by Countries in 2017
Figure USA Interventional Oncology Revenue and Growth Rate (2013-2018)
Figure Canada Interventional Oncology Revenue and Growth Rate (2013-2018)
Figure Mexico Interventional Oncology Revenue and Growth Rate (2013-2018)
Table Europe Interventional Oncology Revenue (Million USD) by Countries (2013-2018)
Figure Europe Interventional Oncology Revenue Market Share by Countries (2013-2018)
Figure Europe Interventional Oncology Revenue Market Share by Countries in 2017
Figure Germany Interventional Oncology Revenue and Growth Rate (2013-2018)
Figure UK Interventional Oncology Revenue and Growth Rate (2013-2018)
Figure France Interventional Oncology Revenue and Growth Rate (2013-2018)
Figure Russia Interventional Oncology Revenue and Growth Rate (2013-2018)
Figure Italy Interventional Oncology Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Interventional Oncology Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Interventional Oncology Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Interventional Oncology Revenue Market Share by Countries in 2017
Figure China Interventional Oncology Revenue and Growth Rate (2013-2018)
Figure Japan Interventional Oncology Revenue and Growth Rate (2013-2018)
Figure Korea Interventional Oncology Revenue and Growth Rate (2013-2018)
Figure India Interventional Oncology Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Interventional Oncology Revenue and Growth Rate (2013-2018)
Table South America Interventional Oncology Revenue by Countries (2013-2018)
Table South America Interventional Oncology Revenue Market Share by Countries (2013-2018)
Figure South America Interventional Oncology Revenue Market Share by Countries (2013-2018)
Figure South America Interventional Oncology Revenue Market Share by Countries in 2017
Figure Brazil Interventional Oncology Revenue and Growth Rate (2013-2018)
Figure Argentina Interventional Oncology Revenue and Growth Rate (2013-2018)
Figure Colombia Interventional Oncology Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Interventional Oncology Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Interventional Oncology Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Interventional Oncology Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Interventional Oncology Revenue Market Share by Countries in 2017
Figure Saudi Arabia Interventional Oncology Revenue and Growth Rate (2013-2018)
Figure UAE Interventional Oncology Revenue and Growth Rate (2013-2018)
Figure Egypt Interventional Oncology Revenue and Growth Rate (2013-2018)
Figure Nigeria Interventional Oncology Revenue and Growth Rate (2013-2018)
Figure South Africa Interventional Oncology Revenue and Growth Rate (2013-2018)
Table Global Interventional Oncology Revenue (Million USD) by Type (2013-2018)
Table Global Interventional Oncology Revenue Share by Type (2013-2018)
Figure Global Interventional Oncology Revenue Share by Type (2013-2018)
Figure Global Interventional Oncology Revenue Share by Type in 2017
Table Global Interventional Oncology Revenue Forecast by Type (2018-2023)
Figure Global Interventional Oncology Market Share Forecast by Type (2018-2023)
Figure Global Radiation Therapy Revenue Growth Rate (2013-2018)
Figure Global Ablation Revenue Growth Rate (2013-2018)
Figure Global Particle Embolization Revenue Growth Rate (2013-2018)
Table Global Interventional Oncology Revenue by Application (2013-2018)
Table Global Interventional Oncology Revenue Share by Application (2013-2018)
Figure Global Interventional Oncology Revenue Share by Application (2013-2018)
Figure Global Interventional Oncology Revenue Share by Application in 2017
Table Global Interventional Oncology Revenue Forecast by Application (2018-2023)
Figure Global Interventional Oncology Market Share Forecast by Application (2018-2023)
Figure Global Liver Cancer Revenue Growth Rate (2013-2018)
Figure Global Lung Cancer Revenue Growth Rate (2013-2018)
Figure Global Kidney Cancer Revenue Growth Rate (2013-2018)
Figure Global Bone Cancer Revenue Growth Rate (2013-2018)
Figure Global Breast Cancer Revenue Growth Rate (2013-2018)
Figure Global Prostate Cancer Revenue Growth Rate (2013-2018)
Figure Global Pancreatic Cancer Revenue Growth Rate (2013-2018)
Figure Global Interventional Oncology Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Interventional Oncology Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Interventional Oncology Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Interventional Oncology Revenue Market Forecast (2018-2023)
Figure Europe Interventional Oncology Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Interventional Oncology Revenue Market Forecast (2018-2023)
Figure South America Interventional Oncology Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Interventional Oncology Revenue Market Forecast (2018-2023)

Companies Profiled

Boston Scientific
BTG
Medtronic
Merit Medical
Terumo
Accuray
Alpinion Medical Systems
Angiodynamics
Atricure
Baylis Medical
Bovie Medical
Brainlab
Bsd Medical
C. R. Bard
C2 Therapeutics
Cardiofocus
Cook Medical
Eckert And Ziegler Bebig
Edap Tms
Elekta
Galil Medical
Healthtronics
Insightec
Medwaves
Mermaid Medical
Microsulis Medical
Monteris Medical

Market Reports Center © Copyright 2019 All rights reserved.

wire transfer
HDFC
ssl